EMEA-001308-PIP01-12-M02
Key facts
| Invented name |
Abraxane
|
| Active substance |
paclitaxel
|
| Therapeutic area |
Oncology
|
| Decision number |
P/0257/2018
|
| PIP number |
EMEA-001308-PIP01-12-M02
|
| Pharmaceutical form(s) |
Powder for suspension for infusion
|
| Condition(s) / indication(s) |
Treatment of solid malignant tumours
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Celgene Europe Limited
Tel. +41 327298500 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-001308-PIP01-12-M02
|
| Compliance opinion date |
21/09/2018
|
| Compliance outcome |
positive
|